209 related articles for article (PubMed ID: 10991841)
1. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Warn PA; Morrissey J; Moore CB; Denning DW
Antimicrob Agents Chemother; 2000 Oct; 44(10):2664-71. PubMed ID: 10991841
[TBL] [Abstract][Full Text] [Related]
2. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
4. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
[TBL] [Abstract][Full Text] [Related]
5. Pradimicin therapy of disseminated Candida tropicalis infection in the mouse.
Restrepo MI; Najvar LK; Fothergill AW; Graybill JR
Med Mycol; 1998 Jun; 36(3):181-4. PubMed ID: 9776832
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Majithiya J; Sharp A; Parmar A; Denning DW; Warn PA
J Antimicrob Chemother; 2009 Jan; 63(1):161-6. PubMed ID: 19008255
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei.
Fisher MA; Shen SH; Haddad J; Tarry WF
Antimicrob Agents Chemother; 1989 Sep; 33(9):1443-6. PubMed ID: 2554797
[TBL] [Abstract][Full Text] [Related]
9. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
[TBL] [Abstract][Full Text] [Related]
10. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
[TBL] [Abstract][Full Text] [Related]
11. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
Ju JY; Polhamus C; Marr KA; Holland SM; Bennett JE
Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of Candida glabrata endophthalmitis with amphotericin B lipid complex (ABLC).
Darling K; Singh J; Wilks D
J Infect; 2000 Jan; 40(1):92-4. PubMed ID: 10762120
[TBL] [Abstract][Full Text] [Related]
13. Comparison of lipid amphotericin B preparations in treating murine zygomycosis.
Ibrahim AS; Gebremariam T; Husseiny MI; Stevens DA; Fu Y; Edwards JE; Spellberg B
Antimicrob Agents Chemother; 2008 Apr; 52(4):1573-6. PubMed ID: 18227182
[TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
[TBL] [Abstract][Full Text] [Related]
16. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B.
Denning DW; Warn P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2592-9. PubMed ID: 10543734
[TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
Capilla J; Clemons KV; Sobel RA; Stevens DA
J Antimicrob Chemother; 2007 Sep; 60(3):673-6. PubMed ID: 17646202
[TBL] [Abstract][Full Text] [Related]
19. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Fong IW; Bannatyne RM; Cheng PC
Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
[TBL] [Abstract][Full Text] [Related]
20. In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2002 Dec; 50(6):1071-4. PubMed ID: 12461036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]